Figure 1
Figure 1. Survival. PFS (A) and OS (B) in response evaluable patients (n = 257) treated with single-agent carfilzomib.

Survival. PFS (A) and OS (B) in response evaluable patients (n = 257) treated with single-agent carfilzomib.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal